Successful thalidomide treatment of severe infantile Behçet disease

scientific article published in March 2001

Successful thalidomide treatment of severe infantile Behçet disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1525-1470.2001.018002143.X
P698PubMed publication ID11358558

P2093author name stringBergman R
Brik R
Shamali H
P2860cites workThalidomide is an inhibitor of angiogenesisQ24563363
Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trialQ34459986
Pediatric onset of Behçet's syndrome with myositis: case report and literature review illustrating unusual featuresQ37908875
Development of polyneuropathy during thalidomide therapyQ42204875
Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells.Q53020061
Behçet's Disease.Q53581660
Thalidomide Responsiveness in an Infant With Behçet's SyndromeQ57052866
P433issue2
P921main subjectthalidomideQ203174
Behçet's diseaseQ911427
P304page(s)143-145
P577publication date2001-03-01
P1433published inPediatric DermatologyQ15753278
P1476titleSuccessful thalidomide treatment of severe infantile Behçet disease
P478volume18

Reverse relations

cites work (P2860)
Q24654208Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome
Q38160325Putative effects of potentially anti-angiogenic drugs in rheumatic diseases
Q37624811Update on the Medical Management of Gastrointestinal Behçet's Disease.

Search more.